October 20, 2014
Monday’s RegMed rhythms – Quiet day, not a lot of news!
October 17, 2014
Advanced Cell (ACTC): Platelets generated from iPSCs – HOLD
October 15, 2014
Wednesday’s RegMed rhythms – stocks opened sharply lower, started to recover, but reversed into a plummet !
October 15, 2014
Histogenics files for $65 M IPO
October 14, 2014
In Memorium
October 10, 2014
Aastrom Biosciences (ASTM) plans to change its name to Vericel Corporation and move HQ to Cambridge, Ma
October 10, 2014
Seriously lower opening expected; RegMed needs to damn the torpedoes
October 9, 2014
RegMed’s yo-yo “walks the dog”
October 1, 2014
Flat to lower open expected; RegMed’s newest re-start - Q4
September 22, 2014
RegMed’s Cytori (CYTX) investors can’t forget or forgive
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.